*Akechi T, Okamura H, Okuyama T, Furukawa TA, Nishiwaki Y, Uchitomi Y (2009). Psychosocial factors and survival after diagnosis of inoperable non-small cell lung cancer. Psycho-Oncology 18, 23–29. *Akechi T, Okuyama T, Sugawara Y, Nakano T, Chima Y, Uchitomi Y (2004). Suicidality in terminally ill Japanese patients with cancer. Cancer 100, 183–191. *Andrykowski MA, Brady M, Hernslee-Downey P (1994). Psychosocial factors predictive of survival after allogeneic bone marrow transplantation for leukaemia. Psychosomatic Medicine 56, 432–439.
Anstey KJ, Luszcz MA (2002). Mortality risk varies according to gender and change in depressive status in very old adults. Psychosomatic Medicine 64, 880–888.
Ayres A, Hoon PW, Franzoni JB (1994). Influence of mood and adjustment on compliance with chemotherapy among breast cancer patients. Journal of Psychosomatic Research 38, 393–402.
Beck AT, Steer RA (1979). Manual of the Revised Beck Depression Inventory. Psychological Corporation: San Antonio, TX.
*Beresford TP, Alfers J, Magnum L, Clapp L, Martin B (2006). Cancer survival probability as a function of ego defense (adaptive) mechanisms versus depressive symptoms. Psychosomatics 47, 247–253. *Bergquist H, Ruth M, Hammerlind E (2007). Psychiatric morbidity among patients with cancer of the esophagus or the gastro-esophageal junction: a prospective, longitudinal evaluation. Diseases of the Esophagus 20, 523–529. *Black SA, Markides KS (1999). Depressive symptoms and mortality in older Mexican Americans. Annales of Epidemiology 9, 45–52. *Broers S, Hengeveld MW, Kaptein AA, Cessie SL, van de Loo de Vries T (1998). Are pretransplant psychological variables related to survival after bone marrow transplantation? A prospective study of 123 consecutive patients. Journal of Psychosomatic Research 45, 341–351. *Brown KW, Levy AR, Rosberger Z, Edgar L (2003). Psychological distress and cancer survival: a follow-up 10 years after diagnosis. Pychosomatic Medicine 65, 636–643. *Buccheri G (1998). Depressive reactions to lung cancer are common and often followed by a poor outcome. European Respiratory Journal 11, 173–178. *Chang G, Orav EJ, Tong MY, Antin JH (2004 a). Predictors of 1-year survival assessed at the time of bone marrow transplantation. Psychosomatics 45, 378–385. *Chang G, Orav EJ, McNamara T, Tong MY, Antin JH (2004 b). Depression, cigarette smoking, and hematopoietic stem cell transplantation outcome. Cancer 101, 782–789.
Chida Y, Hamer M, Wardle J, Steptoe A (2008). Do stress-related psychosocial factors contribute to cancer incidence and survival? Nature Clinical Practice Oncology 5, 468–475.
Cody M, Nichols S, Brennan C, Armes J, Wilson P, Slevin M (1994). Psychosocial risk factors and lung cancer prognosis. Psycho-Oncology 3, 141.
*Colon EA, Callies AL, Popkin MK, McGlave PB (1991). Depressed mood and other variables related to bone marrow transplant survival in acute leukaemia. Psychosomatics 32, 420–425. *Coryell WH (1981). Diagnosis-specific mortality: primary unipolar depression and Briquet's syndrome. Archives of General Psychiatry 38, 939–942.
Coyne JC, Stefanek M, Palmer SC (2007). Psychotherapy and survival in cancer: the conflict between hope and evidence. Psychological Bulletin 133, 367–394.
Cwinkel JG, Behar LC, Zabora JR (1997). Psychosocial factors that affect the survival of adult cancer patients: a review of research. Journal of Psychosocial Oncology 15, 1–34.
*Dalton SO, Schüz J, Engholm G, Johansen C, Küger S, Steding-Jessen M, Storm HH, Olsen JH (2008). Social inequality in incidence of and survival from cancer in a population-based study in Denmark, 1994–2003: summary of findings. European Journal of Cancer 44, 2074–2085. *Derogatis L, Abeloff M, Melisarastos N (1979). Psychological and coping mechanisms and survival time in metastatic cancer. Journal of the American Medical Association 242, 1504–1508.
DiMatteo MR, Lepper HS, Croghan TW (2000). Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Archives of Internal Medicine 160, 2101–2107.
*Edwards J, DiClemente C, Samuels ML (1985). Psychological characteristics: a pretreatment survival marker of patients with testicular cancer. Journal of Psychosocial Oncology 3, 79–94. *Ehlers SL (2000). Effects of depression and substance use on head and neck cancer mortality. Unpublished dissertation (Ph.D. thesis). University of Iowa.
Epstein RM, Street RL (2007). Patient-Centered Communication in Cancer Care: Promoting Healing and Reducing Suffering. NIH Publication No. 07–6225. National Cancer Institute: Bethesda, MD.
*Faller H, Bulzebruck H, Dings P, Lang H (1999). Coping, distress, and survival among patients with lung cancer. Archives of General Psychiatry 56, 756–762. *Faller H, Schmidt M (2004). Prognostic value of depressive coping and depression in survival of lung cancer patients. Psycho-Oncology 13, 359–363. *Forsén A (1991). Psychosocial stress as a risk for breast cancer. Psychotherapy and Psychosomatics 55, 176–185. *Frick E, Motzke C, Fischer N, Busch R, Bumeder I (2005). Is perceived social support a predictor of survival for patients undergoing autologous peripheral blood stem cell transplantation? Psycho-Oncology 14, 759–770. *Gathinji M, McGirt MJ, Attenello FJ, Chaichana KL, Than K, Olivi A, Weingart JD, Brem H, Quinones-Hinojosa A (2009). Association of preoperative depression and survival after resection of malignant brain astrocytoma. Surgical Neurology 71, 299–303.
Giese-Davis J, Spiegel D (2003). Emotional suppression and cancer progression. In Handbook of Affective Sciences (eds. Davidson R. J., Scherer K. and Hill G. G.), pp. 1053–1082. Oxford University Press: Oxford.
Gilbody S, Sheldon T, Wessely S (2006). Should we screen for depression? British Medical Journal 332, 1027–1030.
*Giraldi T, Rodani M, Cartei G, Grassi L (1997). Psychosocial factors and breast cancer: a 6-year Italian follow-up study. Psychotherotherapy and Psychosomatics 66, 229–236. *Goodwin JS, Zhang DD, Ostir G (2004). Effect of depression on diagnosis, treatment, and survival of older women with breast cancer. Journal of the American Geriatrics Society 52, 106–111.
Grassi L, Indelli M, Marzola M, Maestri A, Santini A, Piva E, Boccalon M (1996). Depressive symptoms and quality of life in home-care-assisted cancer patients. Journal of Pain and Symptom Management 12, 300–307.
*Gripp S, Moeller S, Bölke E, Schmitt G, Matuschek C, Asgari S, Asgharzadeh F, Roth S, Budach W, Franz M, Willers R (2007). Survival prediction in terminally ill cancer patients by clinical estimates, laboratory tests, and self-rated anxiety and depression. Journal of Clinical Oncology 25, 3313–3320. *Groenvold M, Petersen MA, Idler E, Bjorner JB, Fayers PM, Mouridsen HT (2007). Psychological distress and fatigue predicted recurrence and survival in primary breast cancer patients. Breast Cancer Research and Treatment 105, 209–219. *Grulke N, Larbig W, Kächele H, Bailer H (2008). Pre-transplant depression as risk factor for survival of patients undergoing allogeneic haematopoietic stem cell transplantation. Psycho-Oncology 17, 480–487.
Hedges LV, Vevea JL (1998). Fixed- and random-effects models in meta-analysis. Psychological Methods 3, 486–504.
*Herrmann C, Brand-Driehorst S, Kaminsky B, Leibing E, Staats H, Rüger U (1998). Diagnostic groups and depressed mood as predictors of 22-month mortality in medical inpatients. Psychosomatic Medicine 60, 570–577. *Hislop TG, Waxler NE, Coldman AJ, Elwood JM, Kan L (1987). The prognostic significance of psychosocial factors in women with breast cancer. Journal of Chronic Diseases 40, 729–735. *Hjerl K, Andersen EW, Keiding N, Mouridsen HT, Mortensen PB, Jorgensen T (2003). Depression as a prognostic for breast cancer mortality. Psychosomatics 44, 24–30. *Hoodin F, Kalbfleisch KR, Thornton J, Ratanatharathorn V (2004). Psychosocial influences on 305 adults' survival after bone marrow transplantation: depression, smoking, and behavioral self-regulation. Journal of Psychosomatic Research 57, 145–154.
Hopko DR, Bell JL, Armento ME, Hunt MK, Lejuez CW (2005). Behavior therapy for depressed cancer patients in primary care. Psychotherapy 42, 236–243.
*Jamieson RN, Burish TG, Wallston KA (1987). Psychogenic factors in predicting survival of breast cancer patients. Journal of Clinical Oncology 5, 768–772.
Juni P, Witschi A, Bloch R, Egger M (1999). The hazards of scoring the quality of clinical trials for meta-analysis. Journal of the American Medical Association 282, 1054–1060.
*Kaplan GA, Reynolds P (1988). Depression and cancer mortality and morbidity: prospective evidence from the Alameda Country study. Journal of Behavioral Medicine 11, 1–13. *Karvonen-Gutierrez CA, Ronis DL, Fowler KE, Terrell JE, Gruber SB, Duffy SA (2008). Quality of life scores predict survival among patients with head and neck cancer. Journal of Clinical Oncology 26, 2754–2760. *Kawamura T, Shioiri T, Takahashi K, Ozdemir V, Someya T (2007). Survival rate and causes of mortality in the elderly with depression: a 15-year prospective study of a Japanese community sample, the Matsunoyama-Niigata suicide prevention project. Journal of Investigative Medicine 55, 106–114.
King DA, Heisel MJ, Lyness JM (2005). Assessment and psychological treatment of depression in older adults with terminal or life-threatening illnesses. Clinical Psychology 12, 339–353.
*Kissane DW, Grabsch B, Clarke DM, Smith GC, Love AW, Bloch S, Snyder RD, Li Y (2007). Supportive-expressive group therapy for women with metastatic breast cancer: survival and psychosocial outcome from a randomized controlled trial. Psycho-Oncology 16, 277–286.
Klinkman S (1997). Competing demands in psychosocial care: a model for the identification and treatment of depressive disorders in primary care. General Hospital Psychiatry 19, 98–111.
*Lam PT, Leung MW, Tse CY (2007). Identifying prognostic factors for survival in advanced cancer patients: a prospective study. Hong Kong Medical Journal 13, 453–459. *Lehto US, Ojanen M, Dyba T, Aromaa A, Kellokumpu-Lehtinen P (2006). Baseline psychosocial predictors of survival in localised breast cancer. British Journal of Cancer 94, 1245–1252. *Lehto US, Ojanen M, Dyba T, Aromaa A, Kellokumpu-Lehtinen P (2007). Baseline psychosocial predictors of survival in localized melanoma. Journal of Psychosomatic Research 63, 151–152. *Leigh H, Percarpio B, Ossahl C, Ungerer J (1987). Psychological predictors of survival in cancer patients undergoing radiation therapy. Psychotherapy and Psychosomatics 47, 65–73.
Levy SM, Roberts DC (1992). Psychoneuroimmunology: prediction of cancer outcomes. In Behavioral Medicine: Stress and Disease Processes (eds. Schneider N., McCabe P. and Baum A.), pp. 165–174. Erlbaum: Hillsdale.
Lipsey MW, Wilson DB (2004). Practical Meta-analysis. Sage: Thousand Oaks, CA.
*Litofsky NS, Farace E, Anderson F, Meyers CA, Huang W, Laws ER (2004). Depression in patients with high-grade glioma: results of the glioma outcome study. Neurosurgery 54, 358–366.
Lloyd-Williams M, Shiels C, Dowrick C (2007). The development of the Brief Edinburgh Depression Scale (BEDS) to screen for depression in patients with advanced cancer. Journal of Affective Disorders 99, 259–264.
*Lloyd-Williams M, Shiels C, Taylor F, Dennis M (2009). Depression – an independent predictor of early death in patients with advanced cancer. Journal of Affective Disorders 113, 127–132. *Loberiza FR, Rizzo JD, Bredeson CN, Antin JH, Horowitz MM, Weeks JC, Lee SJ (2002). Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases. Journal of Clinical Oncology 20, 2118–2126.
Lovibold PF (1998). Long-term stability of depression, anxiety, and stress syndromes. Journal of Abnormal Psychology 107, 520–526.
McGee R, Williams S, Elwood M (1994). Depression and the development of cancer: a meta-analysis. Social Science & Medicine 38, 187–192.
*Mainio A, Hakko H, Timonen M, Niemelä A, Koivukangas J, Räsänen P (2005). Depression in relation to survival among neurosurgical patients with a primary brain tumour: a 5-year follow-up study. Neurosurgery 56, 1234–1241. *Mainio A, Tuunanen S, Hakko H, Niemelä A, Koivukangas J, Räsänen P (2006). Decreased quality of life and depression as predictors for shorter survival among patients with low-grade gliomas: a follow-up from 1990 to 2003. European Archives of Psychiatry and Clinical Neuroscience 256, 516–521.
Massie JW, Popkin MK (1998). Depressive disorders. In Psycho-Oncology (ed. Holland J.), pp. 518–540. Oxford University Press: New York.
*Murphy KC, Jenkins PL, Whittaker JA (1996). Psychosocial morbidity and survival in adult bone marrow transplant recipients – a follow-up study. Bone Marrow Transplant 18, 199–201.
Mystakidou K, Tsilika E, Parpa E, Smyrniotis V, Galanos A, Vlahos L (2007). Beck Depression Inventory: exploring its psychometric properties in a palliative care population of advanced cancer patients. European Journal of Cancer Care 6, 244–250.
*Nakaya N, Saito-Nakaya K, Akizuki N, Yoshikawa E, Kobayakawa M, Fujimori M, Nagai K, Nishiwaki Y, Fukudo S, Tsubono Y, Uchitomi Y (2006). Depression and survival in patients with non-small cell lung cancer after curative resection: a preliminary study. Cancer Science 97, 199–205. *Nakaya N, Saito-Nakaya K, Akechi T, Kuriyama S, Inagaki M, Kikuchi N, Nagai K, Tsugane S, Nishiwaki Y, Tsuji I, Uchitomi Y (2008). Negative psychological aspects and survival in lung cancer patients. Psycho-Oncology 17, 466–473. *Naughton MJ, Hendron JE, Miller AA, Kornblith AB, Chao D, Holland J (2002). The health-related quality of life and survival of small-cell lung cancer patients: results of a companion study to CALGB 9033. Quality of Life Research 11, 235–248.
Onitilo AA, Nietert PJ, Egede LE (2006). Effect of depression on all-cause mortality in adults with cancer and differential effects of cancer site. General Hospital Psychiatry 28, 396–402.
*Osborne RH, Sali A, Aaronson NK, Elsworth GR, Mdzewski B, Sinclair AJ (2004). Immune function and adjustment style: do they predict survival in breast cancer? Psycho-Oncology 13, 199–210. *Ösby U, Brandt L, Correia N, Ekbom A, Sparen P (2001). Excess mortality in bipolar and unipolar disorder in Sweden. Archives of General Psychiatry 58, 844–850. *Palmer JL, Fisch MJ (2005). Association between symptom distress and survival in outpatients seen in a palliative care cancer centre. Journal of Pain and Symptom Management 29, 565–571.
Parmar MB, Torri V, Stewart L (1998). Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in Medicine 17, 2815–2834.
*Penninx BW, Guralnik JM, Pahor M, Ferrucci L, Cerhan JR, Wallace R, Havlik RJ (1998). Chronically depressed mood and cancer risk in older persons. Journal of the National Cancer Institute 90, 1888–1893. *Persky VW, Kempthorne-Rawson J, Shekelle RB (1987). Personality and risk of cancer: 20-year follow-up of the Western Electric Study. Psychosomatic Medicine 49, 435–449. *Phillips KA, Osborne RH, Giles GG, Dite GS, Apicella C, Hopper JL (2008). Psychosocial factors and survival of young women with breast cancer: a population-based prospective cohort study. Journal of Clinical Oncology 26, 4666–4671. *Pirl WF, Temel JS, Billings A, Dahlin C, Jackson V, Prigerson HG, Greer J, Lynch TJ (2008). Depression after diagnosis of advanced non-small cell lung cancer and survival: a pilot study. Psychosomatics 49, 218–224. *Prieto JM, Atala J, Blanch E, Rovina M, Cicera E, Espinal A, Gasto C (2005). Role of depression as a predictor of mortality among cancer patients after stem-cell transplantation. Journal of Clinical Oncology 23, 6063–6071.
Radloff LS (1977). The CES-D scale: a self-report depression scale for research in the general population. Psychological Measurement 1, 385–401.
*Ratcliffe MA, Dawson AA, Walker LG (1995). Eysenck Personality Inventory L-scores in patients with Hodgkin's disease and Non-Hodgkin's lymphoma. Psycho-Oncology 4, 39–45. *Richardson JL, Zarnegar Z, Bisno B, Levine A (1990). Psychosocial status at initiation of cancer treatment and survival. Journal of Psychosomatic Research 34, 189–201. *Ringdal GI, Gotestam KG, Kaasa S, Kvinnsland S, Ringdahl K (1996). Prognostic factors and survival in a heterogeneous sample of cancer patients. British Journal of Cancer 73, 1594–1599.
Roth AJ, Modi R (2003). Psychiatric issues in older cancer patients. Critical Reviews of Oncology/Hematology 48, 185–197.
Satin JR, Linden W, Philipps MJ (2009). Depression as a predictor of disease progression and mortality in cancer patients. Cancer 115, 5349–5361.
*Saito-Nakaya K, Nakaya N, Fujimori M, Akizuki N, Yoshikawa E, Kobyakawa M (2006). Marital status, social support and survival after curative resection in non-small-cell lung cancer. Cancer Science 97, 206–213. *Schulz R, Bookwala J, Knapp JE, Scheier M, Williamson GM (1996). Pessimism, age and cancer mortality. Psychology and Aging 11, 304–309.
Sellick SM, Crooks DL (1999). Depression and cancer: an appraisal of the literature for prevalence, detection, and practice guideline development for psychological interventions. Psycho-Oncology 8, 315–333.
*Sheibani-Rad S, Velanovich V (2006). Effects of depression on the survival of pancreatic adenocarcinoma. Pancreas 32, 58–61. *Shekele RB, Raynor WJ, Ostfeld AM, Garron DC, Bieliauskas LA, Liu S, Maliza C, Paul O (1981). Psychological depression and 17-year risk of death from cancer. Psychosomatic Medicine 43, 118–119.
Sirey J, Bruce ML, Alexopoulos GS (2001). Perceived stigma and patient-rated severity of illness as predictors of antidepressant drug adherence. Psychiatric Services 52, 1615–1620.
Smedslund G, Ringdahl GI (2004). Meta-analysis of the effects of psychosocial interventions on survival time in cancer patients. Journal of Psychosomatic Research 57, 123–131.
Spiegel D, Giese-Davis J (2003). Depression and cancer: mechanisms and disease progression. Biological Psychiatry 54, 269–282.
*Steel JL, Geller DA, Gamblin TC, Olek MC, Carr BL (2007). Depression, immunity, and survival in patients with hepatobiliary carcinoma. Journal of Clinical Oncology 25, 2397–2405. *Stein S, Linn MW, Stein EM (1989). Psychological correlates of survival in nursing home cancer patients. Gerontologist 29, 224–228. *Stommel M, Given BA, Given CW (2002). Depression and functional status as predictors of death among cancer patients. Cancer 94, 2719–2727. *Stockler MR, O'Connell R, Nowak AK, Goldstein D, Turner J, Wilcken NR (2007). Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial. Lancet Oncology 8, 603–612. *Tian J, Chen ZC, Hang LF (2009). The effects of psychological status of the patients with digestive system cancers on prognosis of the disease. Cancer Nursing 32, 230–235. *Tschuschke V, Hertenstein B, Arnold R, Bunjes D, Denzinger R, Kaechele H (2001). Associations between coping and survival time of adult leukemia patients receiving allogeneic bone marrow transplantation: results of a prospective study. Journal of Psychosomatic Research 50, 277–285. *Watson M, Haviland JS, Greer S, Davidson J, Bliss JM (1999). Influence of psychological response on survival in breast cancer: a population-based cohort study. Lancet 354, 1331–1336. *Watson M, Homewood J, Haviland J, Bliss JM (2005). Influence of psychological response on breast cancer survival: 10-year follow-up of population-based cohort. European Journal of Cancer 41, 1710–1714. *Whooley MA, Browner WS (1998). Association between depressive symptoms and mortality in older women. Archives of Internal Medicine 158, 2129–2135. *Wilson KG, Chochinov HM, Skirko MG (2007). Depression and anxiety disorders in palliative cancer care. Journal of Pain and Symptom Management 33, 118–129.
Wulsin LR, Vaillant GE, Wells VE (1999). A systematic review of the mortality of depression. Psychosomatic Medicine 61, 6–17.
Zigmond AS, Snaith RP (1983). The Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinavia 67, 361–370.
*Zonderman AB, Costa P, McCrae RR (1989). Depression as a risk for cancer morbidity and mortality in a nationally representative sample. Journal of the American Medical Association 262, 1191–1195.